WEALTH ENHANCEMENT ADVISORY SERVICES, LLC

Position in HRTX — Heron Therapeutics, Inc. /De/

CIK 1632972 PLYMOUTH, MN

Position in HRTX

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$13,827

+$544 QoQ

Shares Held

32,397

+95.1% QoQ

Ownership

0.017%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#89

of 160 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 2% Shared 0% None 98%

Healthcare · as of Jun 30, 2026

WEALTH ENHANCEMENT ADVISORY SERVICES, LLC holds $166,117,226 across 147 Biotechnology names. HRTX ranks #147 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	45,889	$22,794,442
2	REGN	Regeneron Pharmaceuticals, Inc.	33,880	$21,125,535
3	INCY	Incyte Corp	151,505	$17,174,606
4	EXEL	Exelixis, Inc.	207,728	$11,302,480
5	RPRX	Royalty Pharma plc	179,888	$10,086,320
6	CORT	Corcept Therapeutics Inc	76,278	$6,632,372
7	HALO	Halozyme Therapeutics, Inc.	70,797	$5,541,281
8	AXSM	Axsome Therapeutics, Inc.	19,919	$4,875,573

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$13,827	32,397	+95.1%	Shares	Sole	2026-07-15
2026-03-31	$13,283	16,604	-35.1%	Shares	Sole	2026-04-08
2025-09-30	$32,227	25,577	-31.1%	Shares	Sole	2025-10-29
2025-06-30	$76,854	37,128	+4.2%	Shares	Sole	2025-07-10
2025-03-31	$78,355	35,616	+1.4%	Shares	Sole	2025-04-16
2024-12-31	$53,755	35,134	-22.4%	Shares	Sole	2025-03-17
2024-09-30	$90,093	45,273	+21.2%	Shares	Sole	2024-10-24
2024-06-30	$130,711	37,346	+3.8%	Shares	Sole	2024-07-16
2024-03-31	$99,664	35,980	+0.0%	Shares	Sole	2024-04-15
2023-12-31	$61,150	35,971	-4.4%	Shares	Sole	2024-01-30
2023-09-30	$38,739	37,611	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.